Breast Cancer

Phase 3 VIKTORIA-1 trial shows gedatolisib triplet therapy significantly extends progression-free survival for HR+/HER2- advanced breast cancer.

Learn about rare phyllodes tumors, from benign to malignant grades, including surgical options, recovery and key questions for your oncology team.

Following FDA approval, Veppanu (vepdegestrant) provides a new oral treatment option for patients with ESR1-mutated, ER+/HER2- metastatic breast cancer.

Summer, with its promise of warmth and freedom, can present unexpected challenges for breast cancer survivors navigating life after a mastectomy.

New AHN research shows high-intensity resistance training is safe and essential for breast cancer survivors to gain strength and functional mobility.

Urologist Dr. Susan MacDonald breaks down the differences between soft tissue and blood cancers while highlighting common and rare disease types.

Phase 3 trial shows Datroway significantly extended overall and progression-free survival in patients with previously untreated, advanced TNBC ineligible for immunotherapy.

MD Anderson’s Dr. Wendy Woodward discusses breath-hold techniques, insurance hurdles, and proton therapy’s role in reducing radiation cardiac toxicity.

Dr. Nguyen shares how breast cancer patients in rural areas can overcome travel barriers and confidently discuss clinical trials with their doctors.

Learn why timing and muscle health are vital when using GLP-1 therapy for weight management during and after breast cancer treatment.

Learn about Paget disease of the breast, a rare cancer affecting the nipple. Explore symptoms, diagnostic steps and common treatment options.

Breast cancer survivor Anna Wassman-Cox discusses the Onco-Ballet Foundation and how dance provides healing and community for Stage IV patients.

Lauren Yerkes, founder of POST SWIM, discusses the jarring shift to breast cancer survivorship and the daily practice of reclaiming body confidence.

Dr. Maryam Lustberg discusses the REVITALIZE trial testing CO2 laser therapy to treat vaginal dryness and GSM in breast cancer survivors.

Learn about breast angiosarcoma, a rare blood vessel cancer. Discover the signs of primary and secondary cases to help guide your oncology discussion.

Moving into a new home often means sorting through years of belongings. Sometimes, hidden in a box, we uncover pieces of the past that force us to confront what we’ve endured.

The latest episode of the "Breast Cancer Briefing" podcast highlights the evolving integration of GLP-1 agonists into the breast cancer treatment armamentarium.

The OPTIMAL trial finds oral DHP107 is as effective as IV paclitaxel for patients with advanced breast cancer while reducing side effects like neuropathy.

Before my daughter was diagnosed with breast cancer, the “M” word was not a part of my vocabulary.

After an aggressive breast cancer diagnosis, psychologist Loraine Alderman retires to bridge gaps in patient literature through powerful advocacy.

Dr. W. Fraser Symmans explains how ctDNA is replacing CTCs to monitor breast cancer, detect mutations and track minimal residual disease

Meet Dr. Susan MacDonald, a urologist with stage 4 breast cancer who is the host of CURE's new vlog series, "Demystifying the Darkness."

Learn what an invasive breast cancer diagnosis means and explore treatment options, including surgery and targeted therapy, in this patient education guide.

The DONNA Foundation announced a matching gift challenge supporting fundraising efforts for its annual Celebrate Every Mom campaign.

Breast cancer survivor Dr. Sheri Prentiss discusses shifting oncology care from a "wait and see" approach to early lymphedema intervention and advocacy.